By: Communications
A film crew from BBC Look East recently visited the Bob Champion Research and Education Centre to interview Professor Colin Cooper about developments in the diagnosis of prostate cancer that are being labelled a potential ‘game-changer’.
The current PSA test, which requires a blood sample, is accurate at detecting the cancer which around one in eight men in the UK will develop, however it isn’t able to determine the severity of the cancer, and whether treatment is required, with many men able to live with the more harmless form without intervention.
The two key developments from the team at UEA, which includes Prof Colin Cooper and Dr Rachel Hurst, is a home urine-testing kit which is able to identify the existence and severity of prostate cancer, called the Prostate Urine Risk (PUR) test, and a type of biopsy analysis called the ‘tiger test' which explores a person’s genetics for clues to more aggressive types of the disease. Image: The Prostate Urine Risk test which can be completed in the comfort of the home
It is hoped the PUR test, which is currently going through accreditation, will become available next year, with a regional trial in the works at the Norfolk and Norwich University Hospital, before possibly being expanded UK-wide afterwards.
The exciting developments at the Bob Champion Research and Education Centre over the past eight years have been made possible thanks to £8m in grants and charitable donations, much of which has been driven by the work of the Development, Alumni and Campaigns team.
Experts at UEA and King’s College London have released guidance for GPs on how to manage patients who may be privately accessing weight loss drugs.
Read moreA group of leading mental health professionals and carers have voiced serious concerns over proposed reforms to the Mental Health Act, currently being discussed in parliament.
Read moreThe anti-aging drug Rapamycin has the same life-extending effect as eating less, according to new research from UEA.
Read more